)
Edge1 May 2026
Making the Marlboro Man
The story of Marlboro's transformation from a women's cigarette to a global icon: one of the most effective brand repositionings in history.
Allogene Therapeutics
Allogene Therapeutics (ALLO) investor relations material
Allogene Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary30 Apr, 2026
Executive summary
Annual meeting scheduled for June 18, 2026, in virtual format for shareholders of record as of April 20, 2026.
Shareholders are encouraged to review proxy materials and vote by June 17, 2026.
Voting matters and shareholder proposals
Election of three directors: Deborah Messemer, Vicki Sato, Ph.D., and Owen Witte, M.D.
Advisory vote on executive compensation (say-on-pay) and on the preferred frequency of such votes, with the board recommending annual votes.
Proposal to amend the Certificate of Incorporation to increase authorized common stock from 400,000,000 to 800,000,000 shares.
Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
Board of directors and corporate governance
Board recommends all director nominees for election.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Allogene Therapeutics
- Pivotal trials advance, key data in 2026, cash runway into Q1 2028, net loss narrowed.ALLO
Q4 20253 May 2026 - Annual meeting to address director elections, executive pay, share increase, and auditor ratification.ALLOProxy filing1 May 2026
- Key votes include director elections, executive pay, share increase, and auditor ratification.ALLOProxy filing20 Apr 2026
- Cema-cel achieved 58.3% MRD clearance and strong safety, supporting outpatient use in LBCL.ALLOStudy result20 Apr 2026
- Pivotal allogeneic CAR T programs target multi-billion dollar markets with key data in 2026.ALLOCorporate presentation12 Mar 2026
- Key clinical milestones and manufacturing advances position allogeneic cell therapy for broad impact.ALLOTD Cowen 46th Annual Health Care Conference3 Mar 2026
- ALPHA3 aims to transform lymphoma care by targeting MRD-positive patients with cema-cel.ALLOCiti’s 2026 Virtual Oncology Leadership Summit18 Feb 2026
- Allogeneic CAR T programs advance toward key 2025–2026 milestones with robust financial support.ALLOStifel 2024 Healthcare Conference3 Feb 2026
- Allogeneic cell therapy is poised for broad impact, with pivotal trials and scalable manufacturing underway.ALLOGoldman Sachs Cell Therapy Day3 Feb 2026
Next Allogene Therapeutics earnings date
Q1 202612 May, 2026
Allogene Therapeutics
Next Allogene Therapeutics earnings date
Q1 202612 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage